These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 2360336

  • 1. Time-motion study of intravenous ranitidine admixtures.
    Gonzalez ER, Hruska BM, Elswick RK, Wood CF, Pesko LJ.
    DICP; 1990 Jun; 24(6):590-2. PubMed ID: 2360336
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Personnel time and preparation costs for compounded versus premixed intravenous admixtures in three community hospitals.
    Kirschenbaum BE, Cacace L, Anderson RJ, Ackerman LA.
    Am J Hosp Pharm; 1988 Mar; 45(3):605-8. PubMed ID: 3369464
    [Abstract] [Full Text] [Related]

  • 4. Enterobacter cloacae bloodstream infections in pediatric patients traced to a hospital pharmacy.
    Selenic D, Dodson DR, Jensen B, Arduino MJ, Panlilio A, Archibald LK.
    Am J Health Syst Pharm; 2003 Jul 15; 60(14):1440-6. PubMed ID: 12892028
    [Abstract] [Full Text] [Related]

  • 5. Personnel costs and preparation time in a centralized intravenous admixture program.
    Ryan DM, Daniels CE, Somani SM.
    Am J Hosp Pharm; 1986 May 15; 43(5):1222-5. PubMed ID: 3087164
    [Abstract] [Full Text] [Related]

  • 6. Cost analysis of mixing clindamycin and aminoglycosides.
    Abel SR, Olson SM.
    Am J Hosp Pharm; 1987 Jun 15; 44(6):1385-7. PubMed ID: 3618617
    [Abstract] [Full Text] [Related]

  • 7. Cost analysis of using premixed frozen versus hospital-reconstituted cefazolin sodium injection.
    Havlovic DA, Ivey MF, Grotzinger RP.
    Am J Hosp Pharm; 1987 Apr 15; 44(4):783-7. PubMed ID: 3578311
    [Abstract] [Full Text] [Related]

  • 8. Variable cost per dose of preparing and administering small-volume cephalosporin admixtures. Veterans Administration Pharmacy Service Study Group.
    Am J Hosp Pharm; 1984 Dec 15; 41(12):2624-34. PubMed ID: 6517086
    [Abstract] [Full Text] [Related]

  • 9. Compounding times and contamination rates associated with the preparation of intravenous admixtures in three types of plastic containers.
    Allinson RR, Stach PE, Sherrin TP, Latiolais CJ.
    Am J Hosp Pharm; 1979 Apr 15; 36(4):513-7. PubMed ID: 433938
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Accuracy and efficiency of three methods of preparing piggyback admixtures.
    Fraterrigo CC, Jorgenson JA.
    Am J Hosp Pharm; 1982 Nov 15; 39(11):1920-3. PubMed ID: 7148860
    [Abstract] [Full Text] [Related]

  • 12. Determining staffing for pharmacy chemotherapy admixture program.
    Matanin D, Carlson K, Bonace B.
    Hosp Pharm; 1984 Jul 15; 19(7):514-8. PubMed ID: 10267932
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of gentamicin premixed admixtures: cost and clinical utility.
    Zarowitz BJ, Owen H, Popovich J, Pancorbo S.
    Hosp Pharm; 1987 Mar 15; 22(3):257-60. PubMed ID: 10311980
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Evaluation of compounding accuracy and aseptic techniques for intravenous admixtures.
    Sanders LH, Mabadeje SA, Avis KE, Cruze CA, Martinez DR.
    Am J Hosp Pharm; 1978 May 15; 35(5):531-6. PubMed ID: 350042
    [Abstract] [Full Text] [Related]

  • 16. Adjusting dosage intervals of intermittent intravenous ranitidine according to creatinine clearance: a cost-minimization analysis.
    Connelly JF.
    Hosp Pharm; 1994 Nov 15; 29(11):992, 996-8, 1001. PubMed ID: 10138581
    [Abstract] [Full Text] [Related]

  • 17. Sterility and Stability of Diluted Carprofen in a Multidose Vial in the Laboratory Animal Setting.
    Simonek GD, Alarcio GG, Brignolo LL.
    J Am Assoc Lab Anim Sci; 2017 May 01; 56(3):296-298. PubMed ID: 28535864
    [Abstract] [Full Text] [Related]

  • 18. I.V. admixture contamination rates: traditional practice site versus a class 1000 cleanroom.
    Thomas M, Sanborn MD, Couldry R.
    Am J Health Syst Pharm; 2005 Nov 15; 62(22):2386-92. PubMed ID: 16278330
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Environmental contamination, product contamination and workers exposure using a robotic system for antineoplastic drug preparation.
    Sessink PJ, Leclercq GM, Wouters DM, Halbardier L, Hammad C, Kassoul N.
    J Oncol Pharm Pract; 2015 Apr 15; 21(2):118-27. PubMed ID: 24567041
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.